Integrated Annual Report

Overview

The report presents Duopharma Biotech's inaugural integrated annual report for 2022, combining financial and non-financial information across the Group. It reports 9.0% revenue growth to RM696.72 million and introduces a five-year ESG Strategy. Climate commitments include carbon neutrality by 2030 and net zero carbon emissions by 2050, alongside a double-materiality assessment and Board-level sustainability oversight.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Publication date: 18 April 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Level
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services